Tessa, Synklino, Anagenex and Charm Hit Series A Jackpot
June 9, 2022Building the cell and gene therapy future with partnerships, services and innovation
June 9, 2022Takeda announced results from its Phase III clinical trial on TAK-003, its dengue fever vaccine candidate, at the Northern European Conference of Travel Medicine.
